3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Active not recruiting
11
Recruiting
4
Withdrawn
1
Terminated
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Prostatic Neoplasms
19
Breast Neoplasms
11
Lung Neoplasms
10
Brain Neoplasms
9
Glioblastoma
7
Neoplasm Metastasis
6
Neoplasms
5
Glioma
5
Carcinoma, Renal Cell
5
Carcinoma, Non-Small-Cell Lung
5
Sarcoma
4
Pancreatic Neoplasms
4
Head and Neck Neoplasms
4
Urinary Bladder Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Small Cell Lung Carcinoma
3
Mycosis Fungoides
3
Lymphoma, Non-Hodgkin
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma, B-Cell, Marginal Zone
3
Liver Neoplasms
3
Gliosarcoma
3
Waldenstrom Macroglobulinemia
2
Uterine Cervical Neoplasms
2
Thyroid Neoplasms
2
Sezary Syndrome
2
Rectal Neoplasms
2
Ovarian Neoplasms
2
Oligodendroglioma
2
Neuroendocrine Tumors
2
Interventions
Paclitaxel
20
Carboplatin
16
liposomal doxorubicin
10
Bevacizumab
10
Gemcitabine
8
Topotecan
7
Taxes
7
Cisplatin
7
pembrolizumab
6
Doxorubicin
5
Cyclophosphamide
5
Nivolumab
4
fludarabine
3
Oxaliplatin
3
Immunoglobulin G
3
Hyperthermic Intraperitoneal Chemotherapy
3
Disulfides
3
Cytoreduction Surgical Procedures
3
trebananib
2
talazoparib
2
rucaparib
2
peginterferon alfa-2b
2
olaparib
2
fludarabine phosphate
2
aldesleukin
2
Surgical Procedures, Operative
2
STA 9090
2
Platinum
2
Lenalidomide
2
Irinotecan
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Fallopian Tube Neoplasms
×
Magnetic Resonance Spectroscopy
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled